Elizabeth David Kantor

Sloan-Kettering Inst Can Research

$4,342,298

Attributed

$4,667,663

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $992.8K · FY2018–24

$1M$750K$500K$250K$0

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$4,667,663 · 3

By mechanism

R37$3,993,479 · 1

R21$488,048 · 1

R03$186,136 · 1

Top collaborators

Katsiaryna Bykov1 shared
Mengmeng Du1 shared

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Craig B Thompson$56,520,903
Jason S Lewis$26,024,327
Milind Rajadhyaksha$15,078,152
Deborah Schrag$8,079,366
Samuel Singer$8,089,401

Others in their field

Other Emerging Leaders on “Prevalence”

Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
Leigh A Johnson · University Of North Texas Hlth Sci Ctr$33,290,196
Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
Phd, Stephen Schwartz · Fred Hutchinson Cancer Research Center$26,641,749
Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,473,113
Scarlett Lin-Gomez · University Of California, San Francisco$23,974,147

Research focus

PrevalenceCharacteristicsFollow-UpPharmaceutical PreparationsUnited StatesEpidemiologyDoseLinkAdultWomanClinical ManagementCardiovascular DiseasesClinically RelevantChemotherapyBody Mass IndexComorbidityCancer RecurrenceBreast Cancer SurvivalCaliforniaCancer SurvivalAmerican Society Of Clinical OncologyCancer PatientCardiotoxicityBack